Fluticasone Furoate/Vilanterol (Breo Ellipta) [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

Excerpt

The objective of this review was to perform a systematic review of the beneficial and harmful effects of fluticasone furoate/vilanterol (FF/V; Breo Ellipta) for the treatment of patients with COPD, including chronic bronchitis and/or emphysema.

Publication types

  • Review